Avadel Pharmaceuticals (AVDL) News Today $7.88 -0.28 (-3.37%) As of 02:42 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Avadel and nference Announce Publication of Real-World Data on Sodium Oxybate Treatment Patterns in the Journal of Clinical NeuroscienceApril 17 at 8:00 AM | globenewswire.comResearch Analysts Set Expectations for AVDL Q2 EarningsAvadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) - Equities researchers at Leerink Partnrs issued their Q2 2025 EPS estimates for shares of Avadel Pharmaceuticals in a research note issued to investors on Sunday, April 13th. Leerink Partnrs analyst M. Goodman forecasts that the company willApril 17 at 7:46 AM | marketbeat.comQ1 Earnings Forecast for AVDL Issued By Leerink PartnrsApril 17 at 1:37 AM | americanbankingnews.comQ2 Earnings Estimate for AVDL Issued By Leerink PartnrsApril 16 at 1:36 AM | americanbankingnews.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) Could Be Less Than A Year Away From ProfitabilityApril 14 at 9:15 AM | finance.yahoo.comVanguard Group Inc. Buys 90,147 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL)Vanguard Group Inc. boosted its stake in shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 2.3% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 3,953,247 shares of the company's stock after purchasing an additionApril 14 at 3:21 AM | marketbeat.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) Stake Boosted by Kennedy Capital Management LLCKennedy Capital Management LLC boosted its stake in shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 79.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,056,934 shares of the company's stocApril 13, 2025 | marketbeat.comAvadel Pharmaceuticals (NASDAQ:AVDL) Earns Buy Rating from Needham & Company LLCNeedham & Company LLC restated a "buy" rating and set a $19.00 price target on shares of Avadel Pharmaceuticals in a research report on Wednesday.April 11, 2025 | marketbeat.comNational Bank of Canada FI Takes $2.10 Million Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL)National Bank of Canada FI bought a new position in Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The fund bought 200,000 shares of the company's stock, valued at approximately $2,102,000. National BankApril 11, 2025 | marketbeat.comAvadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)April 10, 2025 | globenewswire.comAvadel Pharmaceuticals (NASDAQ:AVDL) Reaches New 52-Week Low - Here's WhyAvadel Pharmaceuticals (NASDAQ:AVDL) Reaches New 12-Month Low - Time to Sell?April 10, 2025 | marketbeat.comAvadel Pharmaceuticals Provides Update at Needham Virtual Healthcare ConferenceApril 8, 2025 | globenewswire.comAvadel Pharmaceuticals Provides Update at Needham Virtual Healthcare ConferenceApril 8, 2025 | globenewswire.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) Given Consensus Rating of "Buy" by AnalystsAvadel Pharmaceuticals plc (NASDAQ:AVDL - Get Free Report) has been given a consensus recommendation of "Buy" by the eight research firms that are currently covering the company, MarketBeat.com reports. Eight equities research analysts have rated the stock with a buy recommendation. The average 1April 7, 2025 | marketbeat.comCinctive Capital Management LP Buys 36,446 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL)Cinctive Capital Management LP increased its stake in Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 110.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 69,458 shares of the company's stock after purchasingApril 6, 2025 | marketbeat.comAvadel Pharmaceuticals (NASDAQ:AVDL) Reaches New 12-Month Low - Should You Sell?Avadel Pharmaceuticals (NASDAQ:AVDL) Reaches New 52-Week Low - Should You Sell?April 4, 2025 | marketbeat.comKnott David M Jr Takes $3.65 Million Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL)Knott David M Jr purchased a new stake in shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) during the 4th quarter, according to the company in its most recent filing with the SEC. The fund purchased 346,904 shares of the company's stock, valued at approximately $3,646,000. Avadel PhApril 2, 2025 | marketbeat.comAvadel Pharmaceuticals to Present at the 24th Annual Needham Healthcare ConferenceApril 1, 2025 | globenewswire.comAvadel Pharmaceuticals announces publications in CNS Drugs supplementMarch 26, 2025 | markets.businessinsider.comAvadel Announces Publications in CNS Drugs Supplement Highlighting Key Clinical Issues for People with Narcolepsy and Their CliniciansMarch 25, 2025 | globenewswire.comIntech Investment Management LLC Raises Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL)Intech Investment Management LLC lifted its stake in Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 259.6% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 58,758 shares of the company's stock aftMarch 25, 2025 | marketbeat.comAvantax Advisory Services Inc. Grows Stake in Avadel Pharmaceuticals plc (NASDAQ:AVDL)Avantax Advisory Services Inc. raised its stake in shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 90.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 166,456 shares of theMarch 18, 2025 | marketbeat.comBrandes Investment Partners LP Buys 798,415 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL)Brandes Investment Partners LP grew its stake in Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 58.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,173,139 shares of the company's stock aftMarch 16, 2025 | marketbeat.comKing Wealth Management Group Buys Shares of 35,000 Avadel Pharmaceuticals plc (NASDAQ:AVDL)King Wealth Management Group bought a new stake in Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 35,000 shares of the company's stock, valued at approMarch 15, 2025 | marketbeat.comAvadel Pharmaceuticals (NASDAQ:AVDL) Shares Up 4.2% - Still a Buy?Avadel Pharmaceuticals (NASDAQ:AVDL) Trading 4.2% Higher - Here's WhyMarch 14, 2025 | marketbeat.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) Receives Average Rating of "Buy" from AnalystsShares of Avadel Pharmaceuticals plc (NASDAQ:AVDL - Get Free Report) have earned a consensus recommendation of "Buy" from the eight ratings firms that are currently covering the firm, Marketbeat Ratings reports. Eight investment analysts have rated the stock with a buy recommendation. The averageMarch 12, 2025 | marketbeat.comHC Wainwright Has Negative Estimate for AVDL Q2 EarningsAvadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) - HC Wainwright cut their Q2 2025 earnings per share (EPS) estimates for Avadel Pharmaceuticals in a research note issued to investors on Tuesday, March 4th. HC Wainwright analyst O. Livnat now expects that the company will earn ($0.06) per sMarch 8, 2025 | marketbeat.comQ3 Earnings Forecast for AVDL Issued By HC WainwrightAvadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) - Equities researchers at HC Wainwright issued their Q3 2025 earnings per share estimates for Avadel Pharmaceuticals in a research report issued on Tuesday, March 4th. HC Wainwright analyst O. Livnat forecasts that the company will earn $0.01March 7, 2025 | marketbeat.comWhat is Lifesci Capital's Estimate for AVDL Q2 Earnings?Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) - Investment analysts at Lifesci Capital issued their Q2 2025 earnings per share (EPS) estimates for shares of Avadel Pharmaceuticals in a report issued on Monday, March 3rd. Lifesci Capital analyst M. Belghiti expects that the company will pMarch 7, 2025 | marketbeat.comQ1 Earnings Forecast for AVDL Issued By Lifesci CapitalAvadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) - Stock analysts at Lifesci Capital issued their Q1 2025 earnings per share (EPS) estimates for shares of Avadel Pharmaceuticals in a report issued on Monday, March 3rd. Lifesci Capital analyst M. Belghiti forecasts that the company will earnMarch 6, 2025 | marketbeat.comOppenheimer & Co. Inc. Purchases 33,963 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL)Oppenheimer & Co. Inc. boosted its position in Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 102.6% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 67,068 shares of the company's stock afterMarch 6, 2025 | marketbeat.comAvadel Pharmaceuticals (NASDAQ:AVDL) Shares Gap Up - Time to Buy?Avadel Pharmaceuticals (NASDAQ:AVDL) Shares Gap Up - Here's What HappenedMarch 5, 2025 | marketbeat.comAvadel Pharmaceuticals to Present at Upcoming Investor ConferencesMarch 5, 2025 | globenewswire.comNew York State Common Retirement Fund Sells 389,555 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL)New York State Common Retirement Fund cut its stake in shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 92.6% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 31,200 shares of the company's stock after selling 389,555 sharMarch 5, 2025 | marketbeat.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) Q4 2024 Earnings Call TranscriptMarch 4, 2025 | msn.comAvadel Pharmaceuticals (NASDAQ:AVDL) Receives Buy Rating from HC WainwrightHC Wainwright reissued a "buy" rating and set a $21.00 price objective on shares of Avadel Pharmaceuticals in a research report on Tuesday.March 4, 2025 | marketbeat.comAvadel Pharmaceuticals plc (AVDL) Q4 2024 Earnings Call TranscriptMarch 4, 2025 | seekingalpha.comAvadel Pharmaceuticals plc 2024 Q4 - Results - Earnings Call PresentationMarch 3, 2025 | seekingalpha.comAvadel Pharmaceuticals sees FY25 net product revenue $240M-$260MMarch 3, 2025 | markets.businessinsider.comCraig-Hallum Sticks to Its Buy Rating for Avadel Pharmaceuticals (AVDL)March 3, 2025 | markets.businessinsider.comAvadel: Q4 Earnings SnapshotMarch 3, 2025 | sfgate.comAvadel Pharmaceuticals' (AVDL) "Buy" Rating Reaffirmed at Needham & Company LLCNeedham & Company LLC restated a "buy" rating and set a $19.00 price target on shares of Avadel Pharmaceuticals in a research note on Monday.March 3, 2025 | marketbeat.comAvadel Pharmaceuticals (NASDAQ:AVDL) Releases Quarterly Earnings Results, Misses Estimates By $0.02 EPSAvadel Pharmaceuticals (NASDAQ:AVDL - Get Free Report) posted its quarterly earnings data on Monday. The company reported ($0.05) EPS for the quarter, missing the consensus estimate of ($0.03) by ($0.02). Avadel Pharmaceuticals had a negative return on equity of 93.34% and a negative net margin of 52.53%.March 3, 2025 | marketbeat.comAvadel Pharmaceuticals Reiterates 2025 Guidance as it Reports Fourth Quarter and Full Year 2024 Financial ResultsMarch 3, 2025 | globenewswire.comModera Wealth Management LLC Increases Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL)Modera Wealth Management LLC increased its holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 29.6% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 782,567 shares of the company's stock after purchasing an addMarch 3, 2025 | marketbeat.comIs Avadel Pharmaceuticals plc (AVDL) the Best Small Cap Pharma Stocks to Buy Now?March 1, 2025 | msn.comAvadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2024 Financial Results on March 3February 24, 2025 | globenewswire.comAvadel Pharmaceuticals appoints Kevin Springman as VP, salesFebruary 24, 2025 | markets.businessinsider.comAvadel Pharmaceuticals Appoints Kevin Springman as Vice President of SalesFebruary 24, 2025 | globenewswire.comAvadel Pharmaceuticals (AVDL) Projected to Post Quarterly Earnings on MondayAvadel Pharmaceuticals (NASDAQ:AVDL) will be releasing earnings before the market opens on Monday, March 3.February 24, 2025 | marketbeat.com Remove Ads Get Avadel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AVDL and its competitors with MarketBeat's FREE daily newsletter. Email Address AVDL Media Mentions By Week AVDL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AVDL News Sentiment▼0.920.80▲Average Medical News Sentiment AVDL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AVDL Articles This Week▼154▲AVDL Articles Average Week Remove Ads Get Avadel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AVDL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MRUS News Today OGN News Today MOR News Today SWTX News Today CRNX News Today CPRX News Today PTGX News Today VKTX News Today SRRK News Today IMVT News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AVDL) was last updated on 4/17/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avadel Pharmaceuticals plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Avadel Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AVDL Stock Free AVDL Stock Alerts